These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25886174)

  • 1. Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation.
    Bulatov E; Ciulli A
    Biochem J; 2015 May; 467(3):365-86. PubMed ID: 25886174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin-RING Ligases as attractive anti-cancer targets.
    Zhao Y; Sun Y
    Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases.
    Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A
    Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs.
    Gong L; Cui D; Xiong X; Zhao Y
    Adv Exp Med Biol; 2020; 1217():317-347. PubMed ID: 31898236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases.
    Canning P; Bullock AN
    Biochem Soc Trans; 2014 Feb; 42(1):103-7. PubMed ID: 24450635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
    Shafique S; Ali W; Kanwal S; Rashid S
    Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
    Yu Q; Xiong X; Sun Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Biology of CRL Ubiquitin Ligases.
    Rusnac DV; Zheng N
    Adv Exp Med Biol; 2020; 1217():9-31. PubMed ID: 31898219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.
    Jang SM; Redon CE; Aladjem MI
    Front Mol Biosci; 2018; 5():19. PubMed ID: 29594129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural regulation of cullin-RING ubiquitin ligase complexes.
    Duda DM; Scott DC; Calabrese MF; Zimmerman ES; Zheng N; Schulman BA
    Curr Opin Struct Biol; 2011 Apr; 21(2):257-64. PubMed ID: 21288713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cullin protein family.
    Sarikas A; Hartmann T; Pan ZQ
    Genome Biol; 2011; 12(4):220. PubMed ID: 21554755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
    Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
    J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
    Yu Q; Sun Y
    Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly and Regulation of CRL Ubiquitin Ligases.
    Wang K; Deshaies RJ; Liu X
    Adv Exp Med Biol; 2020; 1217():33-46. PubMed ID: 31898220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.
    Hussain M; Lu Y; Liu YQ; Su K; Zhang J; Liu J; Zhou GB
    Pharmacol Res; 2016 Sep; 111():34-42. PubMed ID: 27238229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Guided Design of Peptides as Tools to Probe the Protein-Protein Interaction between Cullin-2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin Ligases.
    Cardote TAF; Ciulli A
    ChemMedChem; 2017 Sep; 12(18):1491-1496. PubMed ID: 28776949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
    Cardote TAF; Gadd MS; Ciulli A
    Structure; 2017 Jun; 25(6):901-911.e3. PubMed ID: 28591624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus NSP1 Requires Casein Kinase II-Mediated Phosphorylation for Hijacking of Cullin-RING Ligases.
    Davis KA; Morelli M; Patton JT
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.
    Canning P; Cooper CDO; Krojer T; Murray JW; Pike ACW; Chaikuad A; Keates T; Thangaratnarajah C; Hojzan V; Marsden BD; Gileadi O; Knapp S; von Delft F; Bullock AN
    J Biol Chem; 2013 Mar; 288(11):7803-7814. PubMed ID: 23349464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.